Name | 4-(1,3-thiazol-4-yl)aniline |
---|---|
Synonyms |
4-Thiazol-4-yl-anilin
4-thiazol-4-yl-aniline |
Density | 1.262g/cm3 |
---|---|
Boiling Point | 347.414ºC at 760 mmHg |
Molecular Formula | C9H8N2S |
Molecular Weight | 176.23800 |
Flash Point | 163.91ºC |
Exact Mass | 176.04100 |
PSA | 67.15000 |
LogP | 2.97350 |
Index of Refraction | 1.66 |
Symbol |
GHS05, GHS06 |
---|---|
Signal Word | Danger |
Hazard Statements | H301-H318 |
Precautionary Statements | P280-P301 + P310-P305 + P351 + P338 |
RIDADR | UN 2811 6.1 / PGIII |
HS Code | 2934100090 |
~% 60759-10-6 |
Literature: Ochiai et al. Yakugaku Zasshi, 1939 , vol. 59, p. 462,468; dtsch. Ref. S. 228, 233 Chem.Abstr., 1954 , p. 0 5449 |
~% 60759-10-6 |
Literature: SELEXAGEN THERAPEUTICS, INC.; VERNIER, Jean-Michel; MAY, John; O'CONNOR, Patrick; RIPKA, William; PINKERTON, Anthony; BOUNAUD, Pierre-Yves; HOPKINS, Stephanie Patent: WO2011/85128 A1, 2011 ; Location in patent: Page/Page column 55 ; |
~% 60759-10-6 |
Literature: EPIZYME, INC.; CHESWORTH, Richard; KUNTZ, Kevin, Wayne; OLHAVA, Edward, James; PATANE, Michael, A. Patent: WO2012/82436 A2, 2012 ; WO 2012/082436 A2 |
~% 60759-10-6 |
Literature: SELEXAGEN THERAPEUTICS, INC.; VERNIER, Jean-Michel; MAY, John; O'CONNOR, Patrick; RIPKA, William; PINKERTON, Anthony; BOUNAUD, Pierre-Yves; HOPKINS, Stephanie Patent: WO2011/85128 A1, 2011 ; |
~% 60759-10-6 |
Literature: Erlenmeyer et al. Helvetica Chimica Acta, 1947 , vol. 30, p. 2058,2061 |
~% 60759-10-6 |
Literature: Kulkarni; Fernandez; Patel; Bellare; Deliwala Journal of pharmaceutical sciences, 1969 , vol. 58, # 7 p. 852 - 857 |
~% 60759-10-6 |
Literature: Erlenmeyer et al. Helvetica Chimica Acta, 1947 , vol. 30, p. 2058,2061 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |